USD
$0.00
(0.00%
)At Close (As of Sep 15, 2025)
$30.85B
Market Cap
-
P/E Ratio
-5.57
EPS
$149.08
52 Week High
$60.40
52 Week Low
HEALTHCARE
Sector
Field | Value (USD) |
---|---|
Gross Profit | $278M |
Total Revenue | $364M |
Cost Of Revenue | $86M |
Costof Goods And Services Sold | $86M |
Operating Income | -$878M |
Selling General And Administrative | $461M |
Research And Development | $598M |
Operating Expenses | $1.2B |
Investment Income Net | - |
Net Interest Income | -$85M |
Interest Income | $2.2M |
Interest Expense | $85M |
Non Interest Income | - |
Other Non Operating Income | - |
Depreciation | - |
Depreciation And Amortization | $11M |
Income Before Tax | -$910M |
Income Tax Expense | $3.7M |
Interest And Debt Expense | - |
Net Income From Continuing Operations | -$914M |
Comprehensive Income Net Of Tax | - |
Ebit | -$825M |
Ebitda | -$814M |
Net Income | -$914M |
Field | Value (USD) |
---|---|
Total Assets | $2B |
Total Current Assets | $1.6B |
Cash And Cash Equivalents At Carrying Value | $555M |
Cash And Short Term Investments | $555M |
Inventory | $99M |
Current Net Receivables | $52M |
Total Non Current Assets | $404M |
Property Plant Equipment | - |
Accumulated Depreciation Amortization Ppe | - |
Intangible Assets | $59M |
Intangible Assets Excluding Goodwill | $59M |
Goodwill | $136M |
Investments | - |
Long Term Investments | - |
Short Term Investments | $879M |
Other Current Assets | $37M |
Other Non Current Assets | - |
Total Liabilities | $1.7B |
Total Current Liabilities | $298M |
Current Accounts Payable | $73M |
Deferred Revenue | - |
Current Debt | - |
Short Term Debt | $12M |
Total Non Current Liabilities | $1.4B |
Capital Lease Obligations | $45M |
Long Term Debt | $1.1B |
Current Long Term Debt | - |
Long Term Debt Noncurrent | - |
Short Long Term Debt Total | $1.1B |
Other Current Liabilities | $212M |
Other Non Current Liabilities | $306M |
Total Shareholder Equity | $285M |
Treasury Stock | - |
Retained Earnings | -$4.4B |
Common Stock | $1.8M |
Common Stock Shares Outstanding | $164M |
Field | Value (USD) |
---|---|
Operating Cashflow | -$684M |
Payments For Operating Activities | - |
Proceeds From Operating Activities | - |
Change In Operating Liabilities | - |
Change In Operating Assets | - |
Depreciation Depletion And Amortization | $11M |
Capital Expenditures | $22M |
Change In Receivables | - |
Change In Inventory | -$17M |
Profit Loss | - |
Cashflow From Investment | -$583M |
Cashflow From Financing | $1.3B |
Proceeds From Repayments Of Short Term Debt | - |
Payments For Repurchase Of Common Stock | - |
Payments For Repurchase Of Equity | - |
Payments For Repurchase Of Preferred Stock | - |
Dividend Payout | - |
Dividend Payout Common Stock | - |
Dividend Payout Preferred Stock | - |
Proceeds From Issuance Of Common Stock | - |
Proceeds From Issuance Of Long Term Debt And Capital Securities Net | - |
Proceeds From Issuance Of Preferred Stock | - |
Proceeds From Repurchase Of Equity | - |
Proceeds From Sale Of Treasury Stock | - |
Change In Cash And Cash Equivalents | - |
Change In Exchange Rate | - |
Net Income | -$914M |
Field | Value (USD) |
---|---|
Gross Profit | $278M |
Total Revenue | $364M |
Cost Of Revenue | $86M |
Costof Goods And Services Sold | $86M |
Operating Income | -$878M |
Selling General And Administrative | $461M |
Research And Development | $598M |
Operating Expenses | $1.2B |
Investment Income Net | - |
Net Interest Income | -$85M |
Interest Income | $2.2M |
Interest Expense | $85M |
Non Interest Income | - |
Other Non Operating Income | - |
Depreciation | - |
Depreciation And Amortization | $11M |
Income Before Tax | -$910M |
Income Tax Expense | $3.7M |
Interest And Debt Expense | - |
Net Income From Continuing Operations | -$914M |
Comprehensive Income Net Of Tax | - |
Ebit | -$825M |
Ebitda | -$814M |
Net Income | -$914M |
Sector: HEALTHCARE
Industry: BIOTECHNOLOGY
Insmed Incorporated, a biopharmaceutical company, develops and markets therapies for patients with rare and serious diseases. The company is headquartered in Bridgewater, New Jersey.